Stay updated on ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The study’s Locations list has been expanded to include numerous additional sites across the United States and internationally (including several states and regions in Belgium, Korea, and Taiwan), and the page shows a revision tag v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T20:40:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Publication notes under PubMed now state that publications are automatically filled from PubMed, and the footer revision number changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:52:24.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Removed the government funding status notice from the page. This change does not affect the study details or enrollment information.
    Difference
    0.2%
    Check dated 2025-11-18T06:58:48.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    No significant changes were detected; the study arms, outcomes, eligibility, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:08:45.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and funding-related limitations are added, plus a version bump to v3.2.0; previous v3.1.0 deletion indicates a version upgrade.
    Difference
    3%
    Check dated 2025-10-06T05:30:54.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T03:03:37.000Z thumbnail image

Stay in the know with updates to ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.